ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

ONF Invites Applications for Fatigue Research

April 19, 1996

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

House Completes Committee Lineups

February 18, 1977